Intra-Cellular Therapies (NASDAQ:ITCI) Now Covered by StockNews.com
Investment analysts at StockNews.com started coverage on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) in a report issued on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Several other analysts have also issued reports on ITCI. Mizuho lowered Intra-Cellular Therapies from an “outperform” rating to a “neutral” rating and […]
Investment analysts at StockNews.com started coverage on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) in a report issued on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Several other analysts have also issued reports on ITCI. Mizuho lowered Intra-Cellular Therapies from an “outperform” rating to a “neutral” rating and […]
